Results
1 -
4 of
4
(Click
here to explore results)
- Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents. Elena González-Hernández, Rubén Aparicio, Mercedes Garayoa, M. José Montero, M. Ángeles Sevilla, Concepción Pérez-Melero
, Med. Chem. Commun.
, 2019
, 10
, 1589
- Organometallic Ru, Os, Rh and Ir half-sandwich conjugates of ispinesib – impact of the organometallic group on the antimitotic activity. Michał Łomzik, Andrzej Błauż, Marta Głodek, Anna Makal, Daniel Tchoń, Daniel Moscoh Ayine-Tora, Christian Hartinger, Błażej Rychlik, Damian Plażuk
, Dalton Trans.
, 2023
, 52
, 11859
- In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues. Abdeslem Bouzina, Yousra Ouafa Bouone, Omar Sekiou, Mohamed Aissaoui, Tan-Sothea Ouk, Abdelhak Djemel, Rachida Mansouri, Malika Ibrahim-Ouali, Zihad Bouslama, Nour-Eddine Aouf
, RSC Adv.
, 2023
, 13
, 19567
- New 1,3,4-thiadiazoles as potential anticancer agents: pro-apoptotic, cell cycle arrest, molecular modelling, and ADMET profile. Mohamed H. Hekal, Paula S. Farag, Magdy M. Hemdan, Amira A. El-Sayed, Aya I. Hassaballah, Wael M. El-Sayed
, RSC Adv.
, 2023
, 13
, 15810